APO Research
Talk to an analyst

APO RESEARCH · REPORT

Contraceptives

Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.

Selected research

Industry Growth & Trends

Global Contraceptives Industry Growth and Trends Forecast to 2032

26 December 2025111 pages

Choose your research edition.

Industry ResearchContraceptives Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Contraceptives Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Contraceptives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Contraceptives Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Contraceptives Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.

Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.

The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Contraceptives market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Contraceptives market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Contraceptives market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Contraceptives.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Contraceptives market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Contraceptives Market by Company

Bayer AG

Pfizer, Inc

Teva Pharmaceutical Industries Ltd

Merck & Co., Inc

Actavis, Inc.

Johnson & Johnson

Gedeon Richter

Novo Nordisk A/S

ZiZhu

Baijingyu

Huazhong

Sine

Reckitt

AbbVie

Church & Dwight

The Cooper Companies

TherapeuticsMD

Afaxys

Mithra Pharmaceuticals

Contraceptives Segment by Type

Pills

Injectable

Condoms

Vaginal Rings

IUDs

Subdermal Implants

Others

Contraceptives Segment by End User

15–24 years

25–34 years

35–44 years

Above 44 years

Contraceptives Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contraceptives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Contraceptives manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Contraceptives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Pills Table 2. Major Company of Injectable Table 3. Major Company of Condoms Table 4. Major Company of Vaginal Rings Table 5. Major Company of IUDs Table 6. Major Company of Subdermal Implants Table 7. Major Company of Others Table 8. Global Contraceptives Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global Contraceptives Sales by Type (2021-2026) & (M Units) Table 10. Global Contraceptives Sales Market Share in Volume by Type (2021-2026) Table 11. Global Contraceptives Sales by Type (2021-2026) & (US$ Million) Table 12. Global Contraceptives Sales Market Share in Value by Type (2021-2026) Table 13. Global Contraceptives Price by Type (2021-2026) & (USD/Unit) Table 14. Global Contraceptives Sales by Type (2027-2032) & (M Units) Table 15. Global Contraceptives Sales Market Share in Volume by Type (2027-2032) Table 16. Global Contraceptives Sales by Type (2027-2032) & (US$ Million) Table 17. Global Contraceptives Sales Market Share in Value by Type (2027-2032) Table 18. Global Contraceptives Price by Type (2027-2032) & (USD/Unit) Table 19. North America Contraceptives Sales by Type (2021-2026) & (M Units) Table 20. North America Contraceptives Sales by Type (2021-2026) & (US$ Million) Table 21. Europe Contraceptives Sales by Type (2021-2026) & (M Units) Table 22. Europe Contraceptives Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific Contraceptives Sales by Type (2021-2026) & (M Units) Table 24. Asia-Pacific Contraceptives Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America Contraceptives Sales by Type (2021-2026) & (M Units) Table 26. Latin America Contraceptives Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa Contraceptives Sales by Type (2021-2026) & (M Units) Table 28. Middle East and Africa Contraceptives Sales by Type (2021-2026) & (US$ Million) Table 29. Contraceptives Industry Trends Table 30. Contraceptives Industry Drivers Table 31. Contraceptives Industry Opportunities and Challenges Table 32. Contraceptives Industry Restraints Table 33. Global Contraceptives Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global Contraceptives Revenue Market Share by Company (2021-2026) Table 35. Global Contraceptives Sales by Company (2021-2026) & (M Units) Table 36. Global Contraceptives Sales Share by Company (2021-2026) Table 37. Global Contraceptives Market Price by Company (2021-2026) & (USD/Unit) Table 38. Global Contraceptives Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global Contraceptives Major Company Production Sites and Headquarters Table 40. Global Contraceptives Company, Product Type & Application Table 41. Global Contraceptives Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global Contraceptives by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global Contraceptives Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global Contraceptives Sales by Region (2021-2026) & (M Units) Table 46. Global Contraceptives Sales Market Share in Volume by Region (2021-2026) Table 47. Global Contraceptives Sales by Region (2021-2026) & (US$ Million) Table 48. Global Contraceptives Sales Market Share in Value by Region (2021-2026) Table 49. Global Contraceptives Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 50. Global Contraceptives Sales by Region (2027-2032) & (M Units) Table 51. Global Contraceptives Sales Market Share in Volume by Region (2027-2032) Table 52. Global Contraceptives Sales by Region (2027-2032) & (US$ Million) Table 53. Global Contraceptives Sales Market Share in Value by Region (2027-2032) Table 54. Global Contraceptives Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 55. Global Contraceptives Sales by End User (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global Contraceptives Sales by End User (2021-2026) & (M Units) Table 57. Global Contraceptives Sales Market Share in Volume by End User (2021-2026) Table 58. Global Contraceptives Sales by End User (2021-2026) & (US$ Million) Table 59. Global Contraceptives Sales Market Share in Value by End User (2021-2026) Table 60. Global Contraceptives Price by End User (2021-2026) & (USD/Unit) Table 61. Global Contraceptives Sales by End User (2027-2032) & (M Units) Table 62. Global Contraceptives Sales Market Share in Volume by End User (2027-2032) Table 63. Global Contraceptives Sales by End User (2027-2032) & (US$ Million) Table 64. Global Contraceptives Sales Market Share in Value by End User (2027-2032) Table 65. Global Contraceptives Price by End User (2027-2032) & (USD/Unit) Table 66. North America Contraceptives Sales by End User (2021-2026) & (M Units) Table 67. North America Contraceptives Sales by End User (2021-2026) & (US$ Million) Table 68. Europe Contraceptives Sales by End User (2021-2026) & (M Units) Table 69. Europe Contraceptives Sales by End User (2021-2026) & (US$ Million) Table 70. Asia-Pacific Contraceptives Sales by End User (2021-2026) & (M Units) Table 71. Asia-Pacific Contraceptives Sales by End User (2021-2026) & (US$ Million) Table 72. Latin America Contraceptives Sales by End User (2021-2026) & (M Units) Table 73. Latin America Contraceptives Sales by End User (2021-2026) & (US$ Million) Table 74. Middle East and Africa Contraceptives Sales by End User (2021-2026) & (M Units) Table 75. Middle East and Africa Contraceptives Sales by End User (2021-2026) & (US$ Million) Table 76. Bayer AG Company Information Table 77. Bayer AG Business Overview Table 78. Bayer AG Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Bayer AG Contraceptives Product Portfolio Table 80. Bayer AG Recent Development Table 81. Pfizer, Inc Company Information Table 82. Pfizer, Inc Business Overview Table 83. Pfizer, Inc Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Pfizer, Inc Contraceptives Product Portfolio Table 85. Pfizer, Inc Recent Development Table 86. Teva Pharmaceutical Industries Ltd Company Information Table 87. Teva Pharmaceutical Industries Ltd Business Overview Table 88. Teva Pharmaceutical Industries Ltd Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Teva Pharmaceutical Industries Ltd Contraceptives Product Portfolio Table 90. Teva Pharmaceutical Industries Ltd Recent Development Table 91. Merck & Co., Inc Company Information Table 92. Merck & Co., Inc Business Overview Table 93. Merck & Co., Inc Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Merck & Co., Inc Contraceptives Product Portfolio Table 95. Merck & Co., Inc Recent Development Table 96. Actavis, Inc. Company Information Table 97. Actavis, Inc. Business Overview Table 98. Actavis, Inc. Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Actavis, Inc. Contraceptives Product Portfolio Table 100. Actavis, Inc. Recent Development Table 101. Johnson & Johnson Company Information Table 102. Johnson & Johnson Business Overview Table 103. Johnson & Johnson Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Johnson & Johnson Contraceptives Product Portfolio Table 105. Johnson & Johnson Recent Development Table 106. Gedeon Richter Company Information Table 107. Gedeon Richter Business Overview Table 108. Gedeon Richter Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Gedeon Richter Contraceptives Product Portfolio Table 110. Gedeon Richter Recent Development Table 111. Novo Nordisk A/S Company Information Table 112. Novo Nordisk A/S Business Overview Table 113. Novo Nordisk A/S Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. Novo Nordisk A/S Contraceptives Product Portfolio Table 115. Novo Nordisk A/S Recent Development Table 116. ZiZhu Company Information Table 117. ZiZhu Business Overview Table 118. ZiZhu Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 119. ZiZhu Contraceptives Product Portfolio Table 120. ZiZhu Recent Development Table 121. Baijingyu Company Information Table 122. Baijingyu Business Overview Table 123. Baijingyu Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 124. Baijingyu Contraceptives Product Portfolio Table 125. Baijingyu Recent Development Table 126. Huazhong Company Information Table 127. Huazhong Business Overview Table 128. Huazhong Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 129. Huazhong Contraceptives Product Portfolio Table 130. Huazhong Recent Development Table 131. Sine Company Information Table 132. Sine Business Overview Table 133. Sine Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 134. Sine Contraceptives Product Portfolio Table 135. Sine Recent Development Table 136. Reckitt Company Information Table 137. Reckitt Business Overview Table 138. Reckitt Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 139. Reckitt Contraceptives Product Portfolio Table 140. Reckitt Recent Development Table 141. AbbVie Company Information Table 142. AbbVie Business Overview Table 143. AbbVie Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 144. AbbVie Contraceptives Product Portfolio Table 145. AbbVie Recent Development Table 146. Church & Dwight Company Information Table 147. Church & Dwight Business Overview Table 148. Church & Dwight Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 149. Church & Dwight Contraceptives Product Portfolio Table 150. Church & Dwight Recent Development Table 151. The Cooper Companies Company Information Table 152. The Cooper Companies Business Overview Table 153. The Cooper Companies Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 154. The Cooper Companies Contraceptives Product Portfolio Table 155. The Cooper Companies Recent Development Table 156. TherapeuticsMD Company Information Table 157. TherapeuticsMD Business Overview Table 158. TherapeuticsMD Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 159. TherapeuticsMD Contraceptives Product Portfolio Table 160. TherapeuticsMD Recent Development Table 161. Afaxys Company Information Table 162. Afaxys Business Overview Table 163. Afaxys Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 164. Afaxys Contraceptives Product Portfolio Table 165. Afaxys Recent Development Table 166. Mithra Pharmaceuticals Company Information Table 167. Mithra Pharmaceuticals Business Overview Table 168. Mithra Pharmaceuticals Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 169. Mithra Pharmaceuticals Contraceptives Product Portfolio Table 170. Mithra Pharmaceuticals Recent Development Table 171. North America Contraceptives Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 172. North America Contraceptives Sales by Country (2021-2026) & (M Units) Table 173. North America Contraceptives Sales Market Share by Country (2021-2026) Table 174. North America Contraceptives Sales Forecast by Country (2027-2032) & (M Units) Table 175. North America Contraceptives Sales Market Share Forecast by Country (2027-2032) Table 176. North America Contraceptives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. North America Contraceptives Market Size by Country (2021-2026) & (US$ Million) Table 178. North America Contraceptives Market Share by Country (2021-2026) Table 179. North America Contraceptives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. North America Contraceptives Market Share Forecast by Country (2027-2032) Table 181. Europe Contraceptives Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 182. Europe Contraceptives Sales by Country (2021-2026) & (M Units) Table 183. Europe Contraceptives Sales Market Share by Country (2021-2026) Table 184. Europe Contraceptives Sales Forecast by Country (2027-2032) & (M Units) Table 185. Europe Contraceptives Sales Market Share Forecast by Country (2027-2032) Table 186. Europe Contraceptives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Europe Contraceptives Market Size by Country (2021-2026) & (US$ Million) Table 188. Europe Contraceptives Market Share by Country (2021-2026) Table 189. Europe Contraceptives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Europe Contraceptives Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific Contraceptives Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific Contraceptives Sales by Country (2021-2026) & (M Units) Table 193. Asia-Pacific Contraceptives Sales Market Share by Country (2021-2026) Table 194. Asia-Pacific Contraceptives Sales Forecast by Country (2027-2032) & (M Units) Table 195. Asia-Pacific Contraceptives Sales Market Share Forecast by Country (2027-2032) Table 196. Asia-Pacific Contraceptives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Asia-Pacific Contraceptives Market Size by Country (2021-2026) & (US$ Million) Table 198. Asia-Pacific Contraceptives Market Share by Country (2021-2026) Table 199. Asia-Pacific Contraceptives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Asia-Pacific Contraceptives Market Share Forecast by Country (2027-2032) Table 201. Latin America Contraceptives Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 202. Latin America Contraceptives Sales by Country (2021-2026) & (M Units) Table 203. Latin America Contraceptives Sales Market Share by Country (2021-2026) Table 204. Latin America Contraceptives Sales Forecast by Country (2027-2032) & (M Units) Table 205. Latin America Contraceptives Sales Market Share Forecast by Country (2027-2032) Table 206. Latin America Contraceptives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Latin America Contraceptives Market Size by Country (2021-2026) & (US$ Million) Table 208. Latin America Contraceptives Market Share by Country (2021-2026) Table 209. Latin America Contraceptives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Latin America Contraceptives Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa Contraceptives Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa Contraceptives Sales by Country (2021-2026) & (M Units) Table 213. Middle East and Africa Contraceptives Sales Market Share by Country (2021-2026) Table 214. Middle East and Africa Contraceptives Sales Forecast by Country (2027-2032) & (M Units) Table 215. Middle East and Africa Contraceptives Sales Market Share Forecast by Country (2027-2032) Table 216. Middle East and Africa Contraceptives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 217. Middle East and Africa Contraceptives Market Size by Country (2021-2026) & (US$ Million) Table 218. Middle East and Africa Contraceptives Market Share by Country (2021-2026) Table 219. Middle East and Africa Contraceptives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 220. Middle East and Africa Contraceptives Market Share Forecast by Country (2027-2032) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. Contraceptives Distributors List Table 224. Contraceptives Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. Contraceptives Image Figure 2. Global Contraceptives Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Contraceptives Market Size (2021-2032) & (US$ Million) Figure 4. Global Contraceptives Sales (2021-2032) & (M Units) Figure 5. Pills Image Figure 6. Global Pills Sales YoY Growth (2021-2032) & (M Units) Figure 7. Injectable Image Figure 8. Global Injectable Sales YoY Growth (2021-2032) & (M Units) Figure 9. Condoms Image Figure 10. Global Condoms Sales YoY Growth (2021-2032) & (M Units) Figure 11. Vaginal Rings Image Figure 12. Global Vaginal Rings Sales YoY Growth (2021-2032) & (M Units) Figure 13. IUDs Image Figure 14. Global IUDs Sales YoY Growth (2021-2032) & (M Units) Figure 15. Subdermal Implants Image Figure 16. Global Subdermal Implants Sales YoY Growth (2021-2032) & (M Units) Figure 17. Others Image Figure 18. Global Others Sales YoY Growth (2021-2032) & (M Units) Figure 19. Global Contraceptives Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global Contraceptives Market Share by Type 2025 VS 2032 Figure 21. North America Contraceptives Sales Market Share in Volume by Type in 2025 Figure 22. North America Contraceptives Sales Market Share in Value by Type in 2025 Figure 23. Europe Contraceptives Sales Market Share in Volume by Type in 2025 Figure 24. Europe Contraceptives Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific Contraceptives Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific Contraceptives Sales Market Share in Value by Type in 2025 Figure 27. Latin America Contraceptives Sales Market Share in Volume by Type in 2025 Figure 28. Latin America Contraceptives Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa Contraceptives Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa Contraceptives Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 Contraceptives Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. 15–24 years Image Figure 34. Global 15–24 years Sales YoY Growth (2021-2032) & (M Units) Figure 35. 25–34 years Image Figure 36. Global 25–34 years Sales YoY Growth (2021-2032) & (M Units) Figure 37. 35–44 years Image Figure 38. Global 35–44 years Sales YoY Growth (2021-2032) & (M Units) Figure 39. Above 44 years Image Figure 40. Global Above 44 years Sales YoY Growth (2021-2032) & (M Units) Figure 41. Global Contraceptives Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Contraceptives Market Share by Application 2025 VS 2032 Figure 43. North America Contraceptives Sales Market Share in Volume by Application in 2025 Figure 44. North America Contraceptives Sales Market Share in Value by Application in 2025 Figure 45. Europe Contraceptives Sales Market Share in Volume by Application in 2025 Figure 46. Europe Contraceptives Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Contraceptives Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Contraceptives Sales Market Share in Value by Application in 2025 Figure 49. Latin America Contraceptives Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Contraceptives Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Contraceptives Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Contraceptives Sales Market Share in Value by Application in 2025 Figure 53. North America Contraceptives Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 54. North America Contraceptives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Contraceptives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Contraceptives Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Contraceptives Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 58. Europe Contraceptives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Contraceptives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Contraceptives Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Contraceptives Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 62. Asia-Pacific Contraceptives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Contraceptives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Contraceptives Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Contraceptives Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 66. Latin America Contraceptives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Contraceptives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Contraceptives Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Contraceptives Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 70. Middle East and Africa Contraceptives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Contraceptives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa Contraceptives Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Contraceptives Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. Contraceptives Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Pills
  • Injectable
  • Condoms
  • Vaginal Rings
  • IUDs
  • Subdermal Implants
  • Others
Applications
  • 15–24 years
  • 25–34 years
  • 35–44 years
  • Above 44 years
Companies covered
  • Bayer AG
  • Pfizer, Inc
  • Teva Pharmaceutical Industries Ltd
  • Merck & Co., Inc
  • Actavis, Inc.
  • Johnson & Johnson
  • Gedeon Richter
  • Novo Nordisk A/S
  • ZiZhu
  • Baijingyu
  • Huazhong
  • Sine
  • Reckitt
  • AbbVie
  • Church & Dwight
  • The Cooper Companies
  • TherapeuticsMD
  • Afaxys
  • Mithra Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Contraceptives Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Contraceptives Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Contraceptives Market by Type
  6. 1.3.1 Pills
  7. 1.3.2 Injectable
  8. 1.3.3 Condoms
  9. 1.3.4 Vaginal Rings
  10. 1.3.5 IUDs
  11. 1.3.6 Subdermal Implants
  12. 1.3.7 Others
  13. 1.4 Global Contraceptives Market Size by Type
  14. 1.4.1 Global Contraceptives Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global Contraceptives Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global Contraceptives Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America Contraceptives Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe Contraceptives Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific Contraceptives Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America Contraceptives Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa Contraceptives Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Contraceptives Industry Trends
  2. 2.2 Contraceptives Industry Drivers
  3. 2.3 Contraceptives Industry Opportunities and Challenges
  4. 2.4 Contraceptives Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Contraceptives Revenue (2021-2026)
  2. 3.2 Global Top Players by Contraceptives Sales (2021-2026)
  3. 3.3 Global Top Players by Contraceptives Price (2021-2026)
  4. 3.4 Global Contraceptives Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Contraceptives Major Company Production Sites & Headquarters
  6. 3.6 Global Contraceptives Company, Product Type & Application
  7. 3.7 Global Contraceptives Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Contraceptives Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Contraceptives Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Contraceptives Tier 1, Tier 2, and Tier 3
4 Contraceptives Regional Status and Outlook
  1. 4.1 Global Contraceptives Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Contraceptives Historic Market Size by Region
  3. 4.2.1 Global Contraceptives Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Contraceptives Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Contraceptives Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Contraceptives Forecasted Market Size by Region
  7. 4.3.1 Global Contraceptives Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Contraceptives Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Contraceptives Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Contraceptives by Application
  1. 5.1 Contraceptives Market by End User
  2. 5.1.1 15–24 years
  3. 5.1.2 25–34 years
  4. 5.1.3 35–44 years
  5. 5.1.4 Above 44 years
  6. 5.2 Global Contraceptives Market Size by End User
  7. 5.2.1 Global Contraceptives Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Contraceptives Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Contraceptives Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by End User
  11. 5.3.1 North America Contraceptives Sales Breakdown by End User (2021-2026)
  12. 5.3.2 Europe Contraceptives Sales Breakdown by End User (2021-2026)
  13. 5.3.3 Asia-Pacific Contraceptives Sales Breakdown by End User (2021-2026)
  14. 5.3.4 South America Contraceptives Sales Breakdown by End User (2021-2026)
  15. 5.3.5 Middle East and Africa Contraceptives Sales Breakdown by End User (2021-2026)
6 Company Profiles
  1. 6.1 Bayer AG
  2. 6.1.1 Bayer AG Company Information
  3. 6.1.2 Bayer AG Business Overview
  4. 6.1.3 Bayer AG Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bayer AG Contraceptives Product Portfolio
  6. 6.1.5 Bayer AG Recent Developments
  7. 6.2 Pfizer, Inc
  8. 6.2.1 Pfizer, Inc Company Information
  9. 6.2.2 Pfizer, Inc Business Overview
  10. 6.2.3 Pfizer, Inc Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer, Inc Contraceptives Product Portfolio
  12. 6.2.5 Pfizer, Inc Recent Developments
  13. 6.3 Teva Pharmaceutical Industries Ltd
  14. 6.3.1 Teva Pharmaceutical Industries Ltd Company Information
  15. 6.3.2 Teva Pharmaceutical Industries Ltd Business Overview
  16. 6.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Teva Pharmaceutical Industries Ltd Contraceptives Product Portfolio
  18. 6.3.5 Teva Pharmaceutical Industries Ltd Recent Developments
  19. 6.4 Merck & Co., Inc
  20. 6.4.1 Merck & Co., Inc Company Information
  21. 6.4.2 Merck & Co., Inc Business Overview
  22. 6.4.3 Merck & Co., Inc Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck & Co., Inc Contraceptives Product Portfolio
  24. 6.4.5 Merck & Co., Inc Recent Developments
  25. 6.5 Actavis, Inc.
  26. 6.5.1 Actavis, Inc. Company Information
  27. 6.5.2 Actavis, Inc. Business Overview
  28. 6.5.3 Actavis, Inc. Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Actavis, Inc. Contraceptives Product Portfolio
  30. 6.5.5 Actavis, Inc. Recent Developments
  31. 6.6 Johnson & Johnson
  32. 6.6.1 Johnson & Johnson Company Information
  33. 6.6.2 Johnson & Johnson Business Overview
  34. 6.6.3 Johnson & Johnson Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Johnson & Johnson Contraceptives Product Portfolio
  36. 6.6.5 Johnson & Johnson Recent Developments
  37. 6.7 Gedeon Richter
  38. 6.7.1 Gedeon Richter Company Information
  39. 6.7.2 Gedeon Richter Business Overview
  40. 6.7.3 Gedeon Richter Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Gedeon Richter Contraceptives Product Portfolio
  42. 6.7.5 Gedeon Richter Recent Developments
  43. 6.8 Novo Nordisk A/S
  44. 6.8.1 Novo Nordisk A/S Company Information
  45. 6.8.2 Novo Nordisk A/S Business Overview
  46. 6.8.3 Novo Nordisk A/S Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Novo Nordisk A/S Contraceptives Product Portfolio
  48. 6.8.5 Novo Nordisk A/S Recent Developments
  49. 6.9 ZiZhu
  50. 6.9.1 ZiZhu Company Information
  51. 6.9.2 ZiZhu Business Overview
  52. 6.9.3 ZiZhu Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 ZiZhu Contraceptives Product Portfolio
  54. 6.9.5 ZiZhu Recent Developments
  55. 6.10 Baijingyu
  56. 6.10.1 Baijingyu Company Information
  57. 6.10.2 Baijingyu Business Overview
  58. 6.10.3 Baijingyu Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Baijingyu Contraceptives Product Portfolio
  60. 6.10.5 Baijingyu Recent Developments
  61. 6.11 Huazhong
  62. 6.11.1 Huazhong Company Information
  63. 6.11.2 Huazhong Business Overview
  64. 6.11.3 Huazhong Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Huazhong Contraceptives Product Portfolio
  66. 6.11.5 Huazhong Recent Developments
  67. 6.12 Sine
  68. 6.12.1 Sine Company Information
  69. 6.12.2 Sine Business Overview
  70. 6.12.3 Sine Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Sine Contraceptives Product Portfolio
  72. 6.12.5 Sine Recent Developments
  73. 6.13 Reckitt
  74. 6.13.1 Reckitt Company Information
  75. 6.13.2 Reckitt Business Overview
  76. 6.13.3 Reckitt Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Reckitt Contraceptives Product Portfolio
  78. 6.13.5 Reckitt Recent Developments
  79. 6.14 AbbVie
  80. 6.14.1 AbbVie Company Information
  81. 6.14.2 AbbVie Business Overview
  82. 6.14.3 AbbVie Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 AbbVie Contraceptives Product Portfolio
  84. 6.14.5 AbbVie Recent Developments
  85. 6.15 Church & Dwight
  86. 6.15.1 Church & Dwight Company Information
  87. 6.15.2 Church & Dwight Business Overview
  88. 6.15.3 Church & Dwight Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Church & Dwight Contraceptives Product Portfolio
  90. 6.15.5 Church & Dwight Recent Developments
  91. 6.16 The Cooper Companies
  92. 6.16.1 The Cooper Companies Company Information
  93. 6.16.2 The Cooper Companies Business Overview
  94. 6.16.3 The Cooper Companies Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 The Cooper Companies Contraceptives Product Portfolio
  96. 6.16.5 The Cooper Companies Recent Developments
  97. 6.17 TherapeuticsMD
  98. 6.17.1 TherapeuticsMD Company Information
  99. 6.17.2 TherapeuticsMD Business Overview
  100. 6.17.3 TherapeuticsMD Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 TherapeuticsMD Contraceptives Product Portfolio
  102. 6.17.5 TherapeuticsMD Recent Developments
  103. 6.18 Afaxys
  104. 6.18.1 Afaxys Company Information
  105. 6.18.2 Afaxys Business Overview
  106. 6.18.3 Afaxys Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Afaxys Contraceptives Product Portfolio
  108. 6.18.5 Afaxys Recent Developments
  109. 6.19 Mithra Pharmaceuticals
  110. 6.19.1 Mithra Pharmaceuticals Company Information
  111. 6.19.2 Mithra Pharmaceuticals Business Overview
  112. 6.19.3 Mithra Pharmaceuticals Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Mithra Pharmaceuticals Contraceptives Product Portfolio
  114. 6.19.5 Mithra Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Contraceptives Sales by Country
  2. 7.1.1 North America Contraceptives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Contraceptives Sales by Country (2021-2026)
  4. 7.1.3 North America Contraceptives Sales Forecast by Country (2027-2032)
  5. 7.2 North America Contraceptives Market Size by Country
  6. 7.2.1 North America Contraceptives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Contraceptives Market Size by Country (2021-2026)
  8. 7.2.3 North America Contraceptives Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Contraceptives Sales by Country
  2. 8.1.1 Europe Contraceptives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Contraceptives Sales by Country (2021-2026)
  4. 8.1.3 Europe Contraceptives Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Contraceptives Market Size by Country
  6. 8.2.1 Europe Contraceptives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Contraceptives Market Size by Country (2021-2026)
  8. 8.2.3 Europe Contraceptives Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Contraceptives Sales by Country
  2. 9.1.1 Asia-Pacific Contraceptives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Contraceptives Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Contraceptives Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Contraceptives Market Size by Country
  6. 9.2.1 Asia-Pacific Contraceptives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Contraceptives Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Contraceptives Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Contraceptives Sales by Country
  2. 10.1.1 South America Contraceptives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Contraceptives Sales by Country (2021-2026)
  4. 10.1.3 South America Contraceptives Sales Forecast by Country (2027-2032)
  5. 10.2 South America Contraceptives Market Size by Country
  6. 10.2.1 South America Contraceptives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Contraceptives Market Size by Country (2021-2026)
  8. 10.2.3 South America Contraceptives Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Contraceptives Sales by Country
  2. 11.1.1 Middle East and Africa Contraceptives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Contraceptives Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Contraceptives Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Contraceptives Market Size by Country
  6. 11.2.1 Middle East and Africa Contraceptives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Contraceptives Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Contraceptives Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Contraceptives Value Chain Analysis
  2. 12.1.1 Contraceptives Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Contraceptives Production Mode & Process
  7. 12.2 Contraceptives Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Contraceptives Distributors
  10. 12.2.3 Contraceptives Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst